Wednesday, July 8, 2026

pharma · Advanced Cancer · Advanced Solid Tumors · TCRT

Alaunos Therapeutics

News and analysis for Alaunos Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

8030 El Rio St, Houston, Texas 77054, US HQ
10 Employees
Public company Type
TCRT · NYSE Ticker
Company details
Status
Public
HQ
8030 El Rio St, Houston, Texas 77054, US
Employees
10
Programs
34
Drugs
12
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Alaunos Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Alaunos Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Alaunos Therapeutics yet.

Back to company overview →